Parexel, one of the world's largest
clinical research organizations (CROs), providing all Phase I-IV clinical development services, has been recognized with the 2023 Commitment to Progress by the Healthcare Businesswomen's Association (HBA). Engagement (ACE) Award". This recognition recognizes companies that have created and implemented initiatives that produce effective results with the goal of closing the gender gap in the
healthcare ecosystem. Parexel was one of two companies selected for its business initiative "Priority: Promote Women". In Leadership". The company received the award at the HBA Annual Conference in Chicago, Illinois."This exciting recognition further reflects Parexel's commitment to a gender-equal corporate culture with a strong commitment to the career development of women at all levels of the organization," said Peyton Howell, Director of
Operations and Growth. "Fighting for gender diversity and inclusion not only creates an environment for our colleagues to thrive, but encourages us to be more innovative to better serve the needs of our clients and patients."Parexel's initiative Priority: Advancing Women in Leadership focuses on improving gender representation and
promoting stronger representation of women in leadership roles, from director to vice president, in the global workforce. The program has had a significant impact on Parexel's bottom line since its inception in 2013, contributing to sales growth, improved financial performance, and increased employee retention and gender equality.Aida Sabo, Global Diversity, Equity and Inclusion, received Linkage's 2023 Women in Leadership Executive Impact Award for her commitment to fostering a work culture that respects gender diversity and inclusion, and for her exceptional commitment to the advancement of women leaders. At Parexel and beyond.Amy McKee,
Chief Medical Officer and Global Director of the Oncology Center of Excellence, was named a 2023 HBA luminary for her contributions to the healthcare industry and role model for active mentoring and career advancement of other women.